Odyssey Therapeutics, Inc. has recently announced a significant update regarding its beneficial ownership. FMR LLC, a prominent investment management firm, has reported owning 13% of the company’s common stock as of September 30, 2026. This development is noteworthy as it indicates a growing interest in Odyssey Therapeutics, which operates within the biological products sector.
Odyssey Therapeutics, Inc., with the ticker ODTX, is classified under the SIC code 2836, which pertains to Biological Products (No Diagnostic Substances). The company is listed on the Nasdaq and is categorized as a non-accelerated filer, smaller reporting company, and an emerging growth company. This filing follows a series of recent submissions, including a 10-Q and an 8-K, both filed on November 4, 2026.
According to the recent Schedule 13G/A filing, FMR LLC beneficially owns 6,239,237 shares of Odyssey Therapeutics, representing 13% of the total outstanding common stock. The filing indicates that FMR LLC has sole voting power over these shares. Additionally, Abigail P. Johnson, a key figure at FMR LLC, is also reported to have significant ownership, holding the same number of shares.
This update may impact various stakeholders, including existing shareholders, potential investors, and competitors in the biological products industry. The increased stake by FMR LLC could signal confidence in Odyssey Therapeutics’ future prospects, potentially influencing other investors' perceptions and decisions.
Looking ahead, the filing does not specify any immediate next steps or actions that will follow this disclosure. However, the heightened interest from a major investment firm like FMR LLC could lead to increased scrutiny and expectations regarding Odyssey Therapeutics’ performance and strategic direction.
Read Next
Sven-Olof Lindblad sells shares in Lindblad Expeditions
Zeo Energy CEO Timothy Bridgewater Acquires 107,955 Shares
Manthripragada Vijay Acquires Additional Shares in Onterris
Laws James Acquires Shares in Onterris, Inc. via RSUs
Eightco Holdings CEO Acquires 100,000 Shares of Stock
Eightco CFO Vroman Acquires 15,000 Shares in Stock Transaction





